Anthem Biosciences Limited logo

Anthem Biosciences Limited (ANTHEM)

Market Closed
13 Aug, 10:00
XNSE XNSE
874. 90
-3.5
-0.3985%
- Market Cap
- P/E Ratio
- Div Yield
446,769 Volume
- Eps
878.4
Previous Close
Add Transaction
Day Range
870.8 891.9
Year Range
579.15 899.9
Want to track ANTHEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ANTHEM closed today lower at ₹874.9, a decrease of -0.3985% from yesterday's close, completing a monthly increase of 12.7521% or ₹98.95. Over the past 12 months, ANTHEM stock gained 34.7036%.
The next announced payment will be in In 1 week on Aug 21, 2026 for a total of ₹2.
The last earnings report, released on Jun 03, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.12%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on MSE (INR).

ANTHEM Chart

Anthem Biosciences Limited (ANTHEM) FAQ

What is the stock price today?

The current price is ₹874.90.

On which exchange is it traded?

Anthem Biosciences Limited is listed on XNSE.

What is its stock symbol?

The ticker symbol is ANTHEM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Anthem Biosciences Limited ever had a stock split?

No, there has never been a stock split.

Anthem Biosciences Limited Profile

- Industry
- Sector
Mr. Ajay Bhardwaj B.Tech., M.S CEO
XNSE Exchange
Y0145S115 CUSIP
India Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Anthem Biosciences Limited is a distinguished contract research, development, and manufacturing organization (CRDMO) located in Bengaluru, India. The company is renowned for its extensive and integrated services that cover the full range of drug discovery, development, and commercial manufacturing processes. Catering primarily to both innovative biotech companies and major pharmaceutical corporations, Anthem Biosciences is particularly noted for its proficiency in the manufacturing of complex, fermentation-based active pharmaceutical ingredients (APIs). This includes a diverse array of products such as probiotics, enzymes, peptides, vitamin analogues, nutritional actives, and biosimilars. Armed with advanced research and development facilities, Anthem manages nearly 200 active projects at different clinical and commercial stages and boasts a portfolio of granted and pending patents worldwide. Serving a diverse client base across 44 countries and over 425 customers, the company is steadfast in its commitment to high standards of quality, compliance, and innovation. Anthem's role as a strategic partner in the life sciences industry is strengthened by a team of dedicated scientists and engineers who are adept at addressing critical challenges encountered in both biological and chemical drug development, reinforcing the company’s reputation as a reliable provider of comprehensive pharmaceutical solutions.

Products and Services

  • Active Pharmaceutical Ingredients (APIs)

    Anthem specializes in manufacturing complex, fermentation-based APIs. These include essential components like probiotics, enzymes, peptides, and vitamin analogues, which are crucial for various therapeutic applications.

  • Probiotics

    The company develops high-quality probiotic products aimed at enhancing gut health, improving digestion, and supporting overall wellness. These probiotics are designed to meet stringent quality standards, ensuring efficacy and safety.

  • Enzymes

    Anthem produces specialized enzymes that are utilized in numerous biotechnological and pharmaceutical processes. These enzymes play a vital role in various biochemical conversions and are tailored to meet specific client demands.

  • Peptides

    The company manufactures a range of peptides with diverse applications in drug development and therapeutic treatments, focusing on quality and biological activity to meet the needs of the pharmaceutical market.

  • Vitamin Analogues

    Anthem is engaged in the production of vitamin analogues that serve as nutritional supplements or therapeutic agents, addressing the nuanced demands of both consumers and healthcare providers.

  • Nutritional Actives

    The company provides nutritional actives beneficial for health and wellness, incorporating advanced scientific research to create innovative and effective products that meet market needs.

  • Biosimilars

    Anthem also develops biosimilars, which are biologic medical products highly similar to already approved reference products, ensuring a cost-effective alternative for patients while maintaining regulatory compliance.

  • End-to-End Pharmaceutical Solutions

    From initial drug discovery through development to commercial manufacturing, Anthem offers end-to-end solutions tailored to their clients’ needs, ensuring a seamless transition across various stages of pharmaceutical product development.

Contact Information

Address: No. 49, F1 & F2, Canara Bank Road
Phone: 91 80 6672 4000